GSK•benzinga•April 14, 2025 at 04:26 PM

Watching GSK; Shares Move Higher, Goldman Sachs Suggesting Arexvy To Be Expanded By CDC; Our Read Of The Slides Suggests The ACIP Voting To Expand Its Recommended Population For Arexvy To Those Aged 50-59 'At-Risk' Is Likely

No summary available.

Read the full article from the original source for complete details and context.

Article published on April 14, 2025 by benzinga